Oramed Pharmaceuticals Inc.
ORMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001176309
In the last 90 days, Oramed Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 84 institutions reported holding it in 13F filings for Q2 2026, worth $80.7M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Oramed Pharmaceuticals Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 116
- +23 vs. Q3 2021
- Shares held
- 8.58M
- +3.16M (+58.5%) vs. Q3 2021
- Total value
- $122.4M
- +$3.57M (+3.0%) vs. Q3 2021
- New holders
- 36
- 44 more added
- Sold out
- 13
- 15 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ORMP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 84 | $80.7M |
| Q1 2026 | 64 | $45.0M |
| Q4 2025 | 57 | $37.2M |
| Q3 2025 | 47 | $24.3M |
| Q2 2025 | 47 | $16.3M |
| Q1 2025 | 52 | $16.6M |
| Q4 2024 | 56 | $18.6M |
| Q3 2024 | 55 | $17.0M |
| Q2 2024 | 59 | $15.2M |
| Q1 2024 | 51 | $15.4M |
| Q4 2023 | 56 | $11.9M |
| Q3 2023 | 56 | $5.99M |
| Q2 2023 | 50 | $8.16M |
| Q1 2023 | 61 | $9.29M |
| Q4 2022 | 77 | $43.2M |
| Q3 2022 | 71 | $25.5M |
| Q2 2022 | 89 | $31.0M |
| Q1 2022 | 103 | $78.4M |
| Q4 2021 | 116 | $122.4M |
| Q3 2021 | 93 | $118.9M |
| Q2 2021 | 75 | $51.4M |
| Q1 2021 | 44 | $12.6M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Oramed Pharmaceuticals Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Goldman Sachs Group Inc | 117,034 | $1.67M | 0.00% | +97,266+492.0% | Added |
| Nuveen Asset Management, LLC | 158,640 | $2.27M | 0.00% | +66,859+72.8% | Added |
| Voloridge Investment Management, LLC | 161,683 | $2.31M | 0.01% | +161,683 | New |
| D. E. Shaw & Co., Inc. | 174,795 | $2.50M | 0.00% | +174,795 | New |
| Renaissance Technologies LLC | 203,200 | $2.90M | 0.00% | +203,200 | New |
| Morgan Jess S & Co Inc | 215,401 | $3.08M | 1.89% | +1,500+0.7% | Added |
| Two Sigma Advisers, LP | 227,300 | $3.25M | 0.01% | +227,300 | New |
| Northern Trust Corp | 243,125 | $3.47M | 0.00% | +17,294+7.7% | Added |
| Geode Capital Management, LLC | 245,345 | $3.50M | 0.00% | −1,626−0.7% | Reduced |
| Vanguard Group Inc | 285,162 | $4.07M | 0.00% | +125,467+78.6% | Added |
| Morgan Stanley | 386,620 | $5.52M | 0.00% | +266,615+222.2% | Added |
| Two Sigma Investments, LP | 402,097 | $5.74M | 0.01% | +402,097 | New |
| State Street Corp | 512,246 | $7.32M | 0.00% | +24,247+5.0% | Added |
| Citadel Advisors LLC | 534,225 | $7.63M | 0.01% | +515,329+2,727.2% | Added |
| Millennium Management LLC | 761,570 | $10.9M | 0.01% | +692,384+1,000.8% | Added |
| BlackRock Inc. | 1,558,607 | $22.3M | 0.00% | +125,059+8.7% | Added |
| Jetstream Capital LLC | 0 | $0 | 0.00% | −120,000−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −66,392−100.0% | Sold out |
| Sabby Management, LLC | 0 | $0 | 0.00% | −40,344−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −37,285−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −23,607−100.0% | Sold out |
| Greylin Investment Mangement Inc | 0 | $0 | 0.00% | −18,900−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −11,972−100.0% | Sold out |
| Dorsey Wright & Associates | 0 | $0 | 0.00% | −5,518−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −2,195−100.0% | Sold out |
| Kings Point Capital Management | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Koshinski Asset Management, Inc. | 0 | $0 | 0.00% | −440−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −95−100.0% | Sold out |
| Eaton Vance Management | 0 | $0 | 0.00% | −65−100.0% | Sold out |